triazolam has been researched along with Eye Pain in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Eye Pain: A dull or sharp painful sensation associated with the outer or inner structures of the eyeball, having different causes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peeler, CE | 1 |
| Villani, CM | 1 |
| Fiorello, MG | 1 |
| Lee, HJ | 1 |
| Subramanian, ML | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparative Analysis of Oral Sedation Versus Standard Intravenous Sedation in Vitreoretinal Surgery With Topical Anesthesia and Sub-tenon's Block[NCT04346095] | Phase 4 | 80 participants (Anticipated) | Interventional | 2020-06-30 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for triazolam and Eye Pain
| Article | Year |
|---|---|
Patient Satisfaction with Oral versus Intravenous Sedation for Cataract Surgery: A Randomized Clinical Trial.
Topics: Administration, Oral; Aged; Anesthetics, Intravenous; Anesthetics, Local; Conscious Sedation; Double | 2019 |